EMBASSY SUITES, INC. – Trademark Portfolio
Entity Type: 03
EMBASSY SUITES, INC. holds 36 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 34 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include E and E EMBASSY SUITES. The owner is based in IRVING, TX.
XEROX CENTER SLUITE 1700 222 LAS COLINAS BLVD.
IRVING, TX 75039
Showing of trademarks Trademarks
Trademark Classifications
EMBASSY SUITES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does EMBASSY SUITES, INC. have?
EMBASSY SUITES, INC. has 36 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned, 29 cancelled.
What trademark classes does EMBASSY SUITES, INC. file in?
EMBASSY SUITES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are EMBASSY SUITES, INC.'s most well-known trademarks?
EMBASSY SUITES, INC.'s registered trademark portfolio includes well-known marks such as E and E EMBASSY SUITES. These are among 3 currently registered trademarks in the portfolio.
What is EMBASSY SUITES, INC.'s trademark registration success rate?
EMBASSY SUITES, INC. has a 8% trademark registration rate, with 3 out of 36 resolved applications resulting in successful registration. Currently, 0 applications are pending review.